VALN
Valneva SE
Stock NASDAQ – Stock Market Prices, News & Analysis
Valneva SE is a French biopharmaceutical company specializing in the development and commercialization of vaccines for human markets.
Valneva SE
VALN
Valneva SE is a French biopharmaceutical company specializing in the development and commercialization of vaccines for human markets.
Price history of Valneva SE
Price history of Valneva SE
Performance & Momentum
Strategic Analysis
Valneva SE • 2026
Valneva SE is a European biotech company specializing in human vaccines, combining immunology expertise with a pharmaceutical positioning. It stands out for its focus on often underexploited vaccine niches, enabling it to address specific healthcare needs with recognized know-how.
- Strong expertise in the development of innovative vaccines with targeted clinical applications
- Positioning in a sector with high barriers to entry and high added value
- Medium-term growth potential linked to the recovery of vaccine markets after the pandemic
- Financial track record marked by volatility and accumulated losses over the long term
- Dependence on clinical success and regulatory approvals, which remain risk factors
Valneva’s recent momentum is positive, driven by a significant improvement in short- and medium-term performance. This trend reflects a better market perception and renewed interest in its vaccine pipeline, strengthening the case for stabilization or even a more durable recovery.
Similar stocks to Valneva SE
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
